glycemia in a dose-dependent manner, i.e., 27% increase with 10 mg/kg and complete elimination with 20 mg/kg. Chemical determinations by HPLC in extracts of freeze-blown brains showed significant increases in the levels of adenosine and its degradation products, inosine and hypoxanthine, during hypo glycemia (P < O.OS). Intracisternal glibenclamide had little ef fect on CBF in normoglycemia, but, like caffeine, produced dose-dependent reductions in the magnitude of the increases in CBF during hypoglycemia, i.e., +66% with glibenclamide-free artificial CSF administration, +2S% with 1 fLmollL glibencl amide, and almost complete blockade (+S%) with 2 fLmollL glibenclamide. These results suggest that adenosine and K ATP channels may play a role in the increases in CBF during hy poglycemia.
potassium channels (K ATP ) might be involved in the mecha nisms of the increases in cerebral blood flow (CBF) that occur in insulin-induced hypoglycemia was examined. Cerebral blood flow was measured by the [14C]iodoantipyrine method in conscious rats during insulin-induced, moderate hypoglycemia (2 to 3 mmollL glucose in arterial plasma) after intravenous injections of 10 to 20 mg/kg of caffeine, an adenosine receptor antagonist, or intracisternal infusion of I to 2 fLmollL glibencl amide, a K ATP channel inhibitor. Cerebral blood flow was also measured in corresponding normoglycemic and drug-free con trol groups. C:erebral blood flow was SI % higher in untreated hypoglycemic than in untreated normoglycemic rats (P < 0.0 1).
Caffeine had a small, statistically insignificant effect on CBF in normoglycemic rats, but reduced the CBF response to hypo-Inhibition of cerebral glucose utilization (CMR g lc) by either limitation of glucose supply (e.g., insulin-induced hypoglycemia) or by blockade of glycolysis with phar macologic doses of 2-deoxyglucose (2-DG) has been shown to result in considerable increases in cerebral blood flow (CBF) (Della Porta et aI., 1964; Norberg and Siesjo, 1976; Abdul-Rahman et aI., 1980; Hollinger and Bryan, 1987; Bryan et aI., 1987; Breier et aI., 1993; Horinaka et aI., 1997a) . The mechanisms underlying these increases are still undefined, but a number of pos-sibilities have been excluded, e.g., direct action of insulin on CBF or cerebral energy metabolism; blood H+, lac tate, and K+ concentrations; blood CO2 and O2 tensions; and nitric oxide production (Horinaka et aI., 1997a) . These glucose-deprived conditions are associated with rises in plasma epinephrine levels, but equivalent rises in plasma epinephrine levels produced by continuous intra venous infusions have been found to have no effects on cerebral blood flow and energy metabolism (Horinaka et aI., 1997b) .
Another possible candidate to be considered is aden osine, which has cerebral vasodilator effects (Berne et a!., 1974; Kuschinsky and Wahl, 1978) . Because it has many properties to be expected of a physiologic regula tor of cerebral vascular tone, it has been proposed as a potential chemical mediator of metabolic regulation of CBF (Rubio et a!., 1978; Winn et aI., 1981b) . For ex ample, adenosine levels in brain tissue rise during cere bral ischemia (Berne et aI., 1974; Nordstrom et aI., 1977; Winn et aI., 1979) , hypotension (Winn et aI., 1980) , hyp oxia (Winn et aI., 1981a) , seizures (Schrader et aI., 1980) , and chemical or electrical stimulation (Sciotti et N. HORlNAKA ET AL. aI., 1993) ; these are all conditions in which cerebral re sistance vessels are also dilated. It is of interest that the increases in CBF in hypoglycemia appear or become prominent when arterial plasma glucose levels decline to about 2.5 to 3 mmollL (Horinaka et aI., 1997a) , levels at which brain glucose utilization and the ability to main tain cerebral tissue ATP levels are reduced (Ghajar et a!., 1982; Suda et aI., 1990) ; conditions that tend to reduce ATP and raise ADP levels are those that favor formation of adenosine (see Discussion).
Whatever the mediator of the increased CBF in glu cose deprivation may be, whether adenosine or some other agent, it must ultimately invoke additional mecha nisms that lead to relaxation of the vascular smooth muscle of the cerebral vessels. Hyperpolarization of smooth muscle cells in response to activation of K+ chan nels and closure of voltage-gated Ca 2 + channels have been shown to lead to dilation of blood vessels (Nelson, 1993) . ATP-sensitive K+ channels (KATP) were first de scribed in cardiac muscle (Noma, 1983) but have also been found in skeletal muscle (Spruce et aI., 1985) , pan creatic l3-cells (Ashcroft et aI., 1984; Cook and Hales, 1984) , neurons (Ashford et aI., 1988) , and vascular smooth muscle (Standen et aI., 1989; Nelson, 1993) . KATP channels are regulated by intracellular ATP and open when intracellular ATP levels fall. They have been shown to be involved in the dilation of cerebral arteries that can be invoked by treatment with KATP channel openers (Faraci and Heistad, 1993) . Decreased glucose concentration has been shown to open KATP channels in pancreatic l3-cells and neurons in the brain (Edwards and Weston, 1993) . KATP channels are also modulated by various normal endogenous substances. For example, the vasodilators calcitonin gene-related peptide and adeno sine have been shown to activate KATP channels in smooth muscle of systemic arteries and gallbladder (Nel son et aI., 1990a; Dart and Standen, 1993; Quayle and Standen, 1994; Zhang et aI., 1994) . Presumably, adeno sine and KATP channels could be acting independently, sequentially, or in concert to increase CBF during glu cose deprivation.
To investigate the possibility that adenosine or KATP channels may play critical roles in the increases in CBF in cerebral glucose deprivation, we have examined the effects of caffeine, a nonselective antagonist of adeno sine receptors, and glibenclamide, a KATP channel blocker, on the CBF response to insulin-induced hypo glycemia in unanesthetized rats. We chose to use caf feine rather than the more potent xanthine theophylline because the latter has greater effects on respiration and arterial Paco2 that are more difficult to control. The re sults show that both caffeine and glibenclamide pro duced dose-dependent reductions in the magnitude of the increases in CBF in hypoglycemia to the point of com plete abolition of the response, suggesting that both J Cereb Blood Flow Metab, Vol. 17, No. 12, 1997 adenosine and KATP channels are involved in the mecha nisms of the effect.
MATERIALS AND METHODS

Chemicals
Chemicals were obtained from the following sources: 4-Iodo- [N-methyl-14C] 
Animals
Normal adult male Sprague-Dawley rats weighing 299 to 378 g were obtained from Taconic Farms (Germantown, NY, U.S.A.) and maintained in animal quarters with a standard 12hour light/dark cycle with humidity and temperature controlled at normal levels. Water and food were allowed ad libitum. All procedures in animals were in strict accordance with the NIH Guide for the Care and Use of Laboratory Animals and were approved by the local Animal Care and Use Committee. The rats were fasted 16 hours before surgery but had free access to water.
The animals were lightly anesthetized with halothane (5% for induction, I % to 1.5% for maintenance) in 70% N20/30% °2, and polyethylene catheters (PE-50, Clay-Adams, Parsip pany, NJ, U.S.A.) were inserted into both femoral arteries and one vein. Because of the limited ability of glibenclamide to traverse the blood-brain barrier, it was necessary to administer it by intracisternal infusion. Silastic catheters (0.0 12-inch inner diameter x 0.025-inch outer diameter, Read Plastic Inc., Rock ville, MD, U.S.A.) were, therefore, implanted in the cisterna magna for the administration of glibenclamide or its vehicle in those rats in which the effects of glibenclamide were studied. After insertion of the catheters the surgical wounds were treated with 5% lidocaine cream and sutured. The animals were then placed in loose-fitting abdominopelvic plaster casts and allowed to recover from the effects of the anesthesia for at least 3 hours before initiation of the procedure for determination of CBF. Body temperature was maintained at 37°C throughout the operative and postoperative periods by a thermostatically con trolled infrared lamp coupled to a rectal temperature probe.
Physiologic variables
Physiologic variables were monitored after the 3-hour period of recovery from anesthesia to assess the physiologic status of the animals. Mean arterial blood pressure (MABP) was mea sured with an air-damped mercury manometer. Arterial blood Pa02, Paco2, and pH were measured with a Corning pH/Blood Gas Analyzer (model No. 170, Corning Medical, Medfield, MA, U.S.A.) . Hematocrit was determined in samples of arterial blood centrifuged in a Microfuge B (Beckman Instruments, Fullerton, CA, U.S.A.). Arterial plasma glucose concentrations were determined with a Beckman Glucose Analyzer 2 (Beck man Instruments).
Experimental procedures
Approximately 3 hours after recovery from the anesthesia, arterial plasma glucose levels, arterial blood hematocrit, gas tensions and pH, and MABP were measured. If these were within normal limits, the experimental procedure was initiated by the intravenous injection of either 0.5 to 1.0 mL physiologic saline or insulin (10 to 20 U/kg) dissolved in an equivalent volume of saline. The procedures specific for studying the ef fects of caffeine or glibenclamide were then implemented as follows.
Effects of caffeine on CBF response to hypoglycemia. Fifteen minutes after the injection of insulin or its saline vehicle, 10 or 20 mg/kg caffeine was injected intravenously; control animals received equivalent volumes of physiologic saline. Because caffeine had' been found to cause hyperventilation and a de crease in Pacob the animals were first placed in small trans parent plastic bags that were intermittently ventilated with 5% CO2 in humidified air at a rate of I to 2 Umin as needed; control rats were treated similarly, except that the bags were ventilated with humidified air lacking CO2, Physiologic vari ables were measured approximately 10 minutes after the caf feine or saline administration and again immediately preceding the measurement of CBF that was initiated 30 minutes after administration of the insulin or its vehicle.
Effect of glibenclamide on CBF response to hypoglycemia.
Simultaneously with the intravenous injections of the saline or insulin, intracisternal infusion of I or 2 fLmollL glibenclamide in a solution of I % dimethyl sulfoxide (DMSO) in artificial CSF was initiated. The DMSO was needed to dissolve the glibenclamide. The infusion was maintained by a Harvard Ap paratus Syringe Infusion Pump 22 (Harvard Apparatus Inc., South Natick, MA, U.S.A.) at a rate of 1.5 fLUmin for approxi mately 30 minutes before and during the I-minute period of CBF measurtfIll ent. Controls were infused with the solution of 1 % DMSO in artificial CSF. Physiologic variables were mea sured 5 minutes before and again immediately before the mea surement of CBF.
Measurement of CBF
Cerebral blood flow was determined by the e4C]IAP method (Sakurada et aI., 1978) with minor modifications as previously described (Horinaka et aI., 1 997a, 1997b) .
Measurement of adenosine, inosine, and hypoxanthine levels in brain tissue
For measurement of the concentrations of adenosine and its degradation products, inosine and hypoxanthine, in brain tis sues of control and hypoglycemic rats, rapidly frozen samples of brain tissue were obtained by the in vivo freeze-blowing technique of Veech et al. (1973) . Approximately 30 minutes after the administration of the saline or insulin, the rats were very lightly anesthetized by an intravenous injection of 0.15 to 0.20 mL of 25 mg/mL sodium thiopental dissolved in saline and immediately placed in the freeze-blowing apparatus that was then activated. The light anesthesia prevented an abrupt rise in plasma glucose levels associated with the handling of the animals during placement. The frozen samples of brain ob tained from the freeze-blowing procedure were pulverized un der liquid nitrogen in a mortar and stored at -80DC until ana lyzed. Another group of rats was injected intravenously with 200 mg/kg 2-DG and studied similarly to determine whether adenosine release in brain tissue occurs in this model of glucose deprivation in which increases in CBF have also been observed (Breier et aI., 1993; Horinaka et aI., 1997a) . In these animals also physiologic variables were measured approximately 10 minutes before and repeated immediately before freeze blowing of the brain.
Each pulverized frozen brain sample was weighed and trans ferred to a glass homogenizer that had been precooled in dry ice. Five milliliters of 70% ethanol, chilled to about -30DC, was added, and the slurry was stirred for at least 2 minutes in a Vortex Mixer (Scientific Industries, Bohemia, NY, U.S.A.); the mixing was frequently interrupted for the homogenizer to be placed in an alcohol bath maintained at -25° to -30°C to keep the samples at the temperature of the bath. An internal standard of 0.5 nmol of 5' -deoxyadenosine was then added to the tissue sample, and the entire mixture was homogenized while the homogenizer tubes were kept in a -20DC bath. The homog enized mixture was centrifuged at 1O,000g for 20 minutes at 2° to 5°C, and the supernatant fractions were transferred to cen trifuge tubes and lyophilized in a SpeedVac Concentrator (Sa vant Instruments, Farmingdale, NY, U.S.A.). After drying, 150 fLL of H20 was added to reconstitute the homogenate, and undissolved residue was removed by centrifugation at 10,000g for 20 minutes at 2° to 5°C. The supernatant fractions of this last centrifugation were then assayed by HPLC. Samples were either analyzed immediately or stored at -80°C, but never longer than 1 week. Each sample was analyzed in duplicate, and the average of the two values was used.
HPLC analyses were carried out with a Gilson liquid chro matograph system (Gilson Medical Electronics, Middleton, WI, U.S.A.) with UV detection at 259 nm. Adenosine, inosine, hypoxanthine, and the 5' -deoxyadenosine internal standard were separated on a Zorbax SB-C8 analytical column (3.5-fLm particle size; 4.6-mm inner diameter x 15 cm) and a Zorbax SB-C8 guard column (MAC-MOD Analytical Inc., Chadds Ford, PA, U.S.A.). The solvent used for the mobile phase was a modification of one used by James and Richardson (1993) ; it consisted of a gradient mixture of 2.5 mmol/L tetrabutylam monium phosphate (pH 6.4) (Solvent A) and methanol (Solvent B) programmed as follows: (1) 100% A and 0% B at a flow rate of 0.5 mUmin for the first 10 minutes; (2) increase in B to 2% and flow rate increase to I mUmin for the next 4 minutes; (3) increase in B to 21 % with flow rate maintained at 1 mUmin for the next 31 minutes; (4) gradual increase in B to 100% during the next 5 minutes with flow rate at 1 mUmin and maintained at 100% for 10 minutes for washout. The column was equili brated with 100% Solvent A for 10 minutes at a rate of 0.5 mUmin between analyses. With these gradient elution condi tions, the retention times for hypoxanthine, inosine, adenosine, and 5' -deoxyadenosine, determined with reference standards, were 13.4, 18.6, 31.6, and 41.7 minutes, respectively. The iden tity of adenosine was confirmed by its disappearance after its incubation with I unit of adenosine deaminase at room tem perature for I minute.
Statistical analysis
Data are presented as means ± SD. Statistical significance of differences were determined by Student's t-tests for group comparisons or paired comparisons when appropriate.
RESULTS
Effects of glucose deprivation on adenosine release in brain tissue
To determine whether glucose deprivation increases adenosine release in brain tissue, rats were made hypo glycemic with insulin or given pharmacologic doses of 2-DG to reproduce conditions shown to increase CBF in previous studies (Horinaka et aI., 1997 a) and confirmed in the present studies (see below); control animals re ceived equivalent injections of saline. In these experi ments, however, CBF was not measured; instead the N. HOR1NAKA ET AL.
brains were rapidly freeze-blown and analyzed for their contents of adenosine as well as its metabolic products because of its rapid metabolism. The changes in the val ues of the physiologic variables during glucose depriva tion in these animals were comparable to those seen in other animals similarly treated (Horinaka et aI., 1997 a) .
In the rats with insulin-induced hypoglycemia (n = 9), arterial plasma glucose level fell from I 16 ± 12 (mean ± SD) to 34 ± 6 mg/dL (P < 0.0 I); arterial blood Paco2 remained uncbanged at 39 ± 2 mm Hg; and pH fell from 7.45 ± 0.01 to 7.40 ± 0.03 (P < 0.01). In the 2-DG-treated animals (n = 9) arterial plasma glucose level rose from III ± 12 to 201 ± 33 mg/dL (P < 0.01); arterial blood Paco2 rose from 38 ± 2 to 42 ± 2 mm Hg (P < 0.01); and pH fell from 7.45 ± 0.02 to 7.39 ± 0.02 (P < 0.01).
Glucose deprivation was clearly associated with pro nounced statistically significant rises in the levels of adenosine and its metabolites in the brain, particularly of its initial degradation product, inosine ( Table 1) . The increases with pharmacologic doses of 2-DG were con siderably greater than with the insulin-induced hypogly cemia, averaging 8-fold, 41-fold, and 13-fold for aden osine, inosine, and hypoxanthine, respectively.
Effects of intravenous caffeine administration
Physiologic variables. Acute intravenous injections of caffeine cause8 hyperventilation and behavioral changes, e.g., intense grooming, sniffing, chewing, head-bobbing, and paw-pushing, which persisted throughout the experi mental period; these behavioral changes were more pro nounced with the larger dose of caffeine. The hyperven tilation caused increases in arterial Pao2 and pH and a decrease in Paco2. The Paco2 level was, therefore, main tained at normal levels by providing 5% CO2 in the inspired air (Table 2) . Arterial plasma glucose levels were elevated from baseline levels by the caffeine treat ments in the normoglycemic rats. All other measured blood variables were unaffected by the caffeine treat ment ( Table 2) .
Values of the blood variables in the rats with insulin induced hypoglycemia, whether treated with caffeine or saline, showed no statistically significant differences from those in the corresponding controls, except for the arterial plasma glucose concentration, which was re duced to an average of 41 to 42 mg/dL (2.3 mmollL) compared with 144 to 167 mg/dL (8 to 9.3 mmol/L) in the normoglycemic rats at the time of the CBF measure ment (P < 0.01) ( Table 2) .
Effects on the CBF res p onse to insulin-induced hy p o glycemia. Cerebral blood flow was increased in insulin induced hypoglycemia from a level of 113 ± 18 mL·100 g-I 'min-I (means ± SD, n = 7) in saline-treated normo glycemic controls to 171 ± 34 mL·100 g-1 'min-1 (n = 7), a statistically significant rise of 51 % (P < 0.01) (Fig.  1) . Caffeine administration in doses of 10 and 20 mg/kg tended to reduce CBF in the normoglycemic rats to 96 ± 8 (n = 6) and 111 ± 14 (n = 6) mL·100 g-I 'min-t , respectively, but these changes were not statistically sig nificant (Fig. 1) . The rise in CBF in response to the insulin-induced hypoglycemia was, however, markedly diminished by caffeine in a dose-dependent manner (Fig.  1) . In rats given the dose of 10 mg/kg, hypoglycemia raised CBF to 123 ± 22 mL·100 g-I 'min-I (n = 7) from a level of 96 ± 8 mL·100 g-1 'min-1 (n = 7) in the normoglycemic controls, a statistically significant in crease (P < 0.05), but only of 27% compared with the 51 % rise in rats not pretreated with caffeine. The dose of 20 mg/kg, however, completely eliminated the increase in CBF caused by hypoglycemia; CBF was 104 ± 20 mL·IOO g-1 'min-1 (n = 6) in the hypoglycemic rats versus III ± 14 mL·100 g-l 'min-I (n = 6) in the nor moglycemic, caffeine-treated controls, a statistically in significant 6% decrease (Fig. 1) .
Effects of intracisternal glibenclamide infusion
Physiologic variables. Intracisternally infused glib enclamide had no significant effects on the blood vari ables in normoglycemic control or insulin-treated hypo glycemic rats (Table 3) .
Effects on the CBF res p onse to insulin-induced hy p o glycemia. Glibenclamide had no statistically significant effects on CBF in normoglycemic rats; CBF was 100 ± 16 mL·100 g-I 'min-I (mean ± SD, n = 5) in normogly cemic, artificial CSF-infused control rats compared with Values are expressed as mean ± SD of the number of animals in parentheses. * p < 0.05, t p < 0.0 1. :j: P < 0.00 1 compared with normoglycemic saline-treated control group (grouped t test). 101 ± 21 (n = 5) and 91 ± 12 (n = 4) mL· 100 g-l . min-1 in normoglycemic rats infused with 1 /-LmollL and 2 /-LmollL glibenc1amide. respectively (Fig. 2) , As with caf feine, however, glibenc1amide blocked the increases in CBF in hypoglycemia in a dose-dependent manner. In rats infused with artificial CSF alone, insulin-induced hypoglycemia increased CBF from 100 ± 16 (n = 5) to 166 ± 11 (n = 4) mL· 100 g-l . min-1 (+66%). With the infusion of 1 /-Lmol/L glibenclamide the increase in CBF in hypoglycemia was reduced to only +25%, i.e., from 101 ± 21 (n = 5) to 126 ± 11 (n = 4) mL· 100 g-I 'min-1 (Fig. 2) . The infusion of 2 /-Lmol/L glibenclamide almost completely abolished the increase in CBF caused by hy poglycemia, i.e., from 91 ± 12 (n = 4) to 96 ± 11 (n = 4) mL·100 g-I 'min-1 , a 5% change that was statistically insignificant (Fig. 2) .
DISCUSSION
The present study confirms that insulin-induced hypo glycemia results in marked increases in CBF (Della Porta et aI., 1964; Norberg and Siesjo, 1976; Abdul-Rahman et aI., 1980; Hollinger and Bryan, 1987; Bryan et aI., 1987; Horinaka et aI., 1997a) . In previous studies (Horinaka et aI., 1997 (Horinaka et aI., a, 1997 we systematically examined a number of potential mediators of this response but could identify none that was critical to the mechanism of the effect. Excluded were a number of changes associated with in sulin-induced hypoglycemia: direct action of insulin; al tered blood Paco2, Pao2, and pH; decreased plasma K+ concentration; increased arterial lactate concentration; and increased plasma epinephrine level. Also excluded was a role for nitric oxide in this effect (Horinaka et aI., 1997a) . The present study demonstrates that two drugs, caffeine and glibenclamide, can in a dose-dependent manner inhibit and eventually abolish the response. Be cause much is known about the fundamental modes of action of these drugs, these results may lead to a better understanding of the mechanisms of the increase in CBF in hypoglycemia. osine at the adenosine receptors, and cerebral vascular smooth muscle is endowed with several types of purin ergic receptors, including some specific for adenosine (Edvinsson et aI., 1993) , Adenosine has potent vasodila tor actions and has long been considered a possible meta bolic regulator of the cerebral circulation (Berne et aI., 1974 , Kuschinsky and Wahl, 1978 , Rubio et aI., 1978 Winn et aI., 1981b; Edvinsson et aI., 1993) . Its role in the normal regulation of cerebral blood flow is, however, still uncertain, The main argument against such a role is that extracellular adenosine levels in brain in normal physiologic states appear to be too low to have important influence on the cerebral circulation (Edvinsson et aI., 1993) , Extracellular adenosine concentration may not, however, reflect its true levels at the receptor sites on the blood vessels or the magnitude of adenosine release, Adenosine can be formed by dephosphorylation of AMP by 5' -nucleotidase, an ectoenzyme bound on the mem branes of the astrocytic endfeet investing the intracere bral vessels (Kreutzberg et aI., 1978) ; Adenosine con centrations in perivascular fluids may, therefore, exceed those in interstitial fluid. Furthermore, adenosine is rap idly degraded by adenosine deaminase to inosine, which is then deribosylated by purine nucleoside phosphorylase to hypoxanthine. The steady state concentration of aden osine in brain tissue may, therefore, not reflect the dy namic turnover of adenosine in the brain, In our studies we observed approximately fourfold increases in adeno sine in brain in hypoglycemia, but concentrations of its immediate degradation product, inosine, and its second ary product, hypoxanthine, also increased about 3.6-fold and 2.3-fold, respectively. We also measured the con centrations of adenosine and its metabolites in brain dur ing blockade of glycolysis by pharmacologic doses of 2-DG, another glucose-deprived condition in which in creases in CBF are even greater (Breier et aI., 1993; Horinaka et aI" 1997a) . In this condition there is even more pronounced adenosine release inasmuch as brain levels of adenosine, inosine, and hypoxanthine increased 8-fold, 42-fold, and 14-fold, respectively. Ruth et aI. (1993) have also observed increases in both CBF and brain interstitial adenosine levels, determined by micro dialysis, during insulin-induced hypoglycemia in anes thetized piglets. Clearly there is an enhanced release of adenosine in brain in the glucose-deprived conditions in which CBF is enhanced.
There are at least four adenosine receptor subtypes, AI' A2A, A2 B , and A3. The vasodilating effect of aden osine is associated with activation of A2 receptors (Ed vinsson et aI., 1993) and the stimulation of adenylate cyclase activity and cyclic AMP (cAMP) formation. The A I -receptor has a very high affinity for adenosine whereas the �2-receptor has a low affinity. Conse quently, low doses of caffeine, which is an adenosine receptor antagonist, block the low-affinity adenosine A2receptors whereas the high-affinity adenosine A 1receptors are blocked at much higher doses (Daly et aI., 1983) .
Caffeine easily crosses the blood-brain barrier by simple diffusion and carrier-mediated transport (McCall et aI., 1982) and rapidly enters brain (Axelrod and Rei chenthal, 1953) , which seems to be the organ most sen sitive to caffeine (Dews, 1982) . Thithapandha et aI. (1972) have shown that CSF levels reach half plasma levels in 4 to 8 minutes, and brain levels of caffeine remain almost constant for the first hour after intrave nous administration. At 10 and 20 mg/kg in our studies, caffeine itself had no statistically significant effects on CBF in normoglycemic rats but reduced the increases in CBF during insulin-induced hypoglycemia in a dose dependent manner to the point of complete abolition of the response (Fig. 1) . These results suggest that the ac tion of adenosine on its receptors is critical to the in crease in CBF during hypoglycemia.
Intracisternal infusions of glibenclamide had effects similar to those of caffeine, i.e., little effect on CBF in normal rats but a dose-dependent inhibition of the in crease in CBF in insulin-induced hypoglycemia to the point of complete blockade of the response (Fig. 2) . Glibenclamide is a selective inhibitor of ATP-sensitive K+ channels, which play an important role in regulating the tone of vascular smooth muscle (Standen et aI., 1989; Nelson et aI., 1990a,b) . These channels are inhibited by ATP. When disinhibited by a fall in ATP levels, they open and allow K+ efflux from the cells, resulting in hyperpolarization of the cell membrane, reduced Ca 2 + influx into the cells through voltage-dependent Ca 2 + channels, and relaxation of the smooth muscle of the blood vessels (Standen et aI., 1989; Nelson et aI., 1990b Nelson et aI., , 1993 . Abolition of the CBF response to hypoglycemia by blockade of the KATP channels with glibenclamide suggests that opening of KATP channels is an important component of the mechanisms of the CBF response to hypoglycemia. It is noteworthy that glibenclamide also blocks the 2-DG-induced hyperpolarization and vasodi lation in rat coronary arteries (Conway et aI., 1994) . If the blockade of the CBF response to hypoglycemia by either caffeine or glibenclamide is attributed to their presumed most likely actions, i.e., caffeine antagonism of adenosine at adenosine receptors and glibenclamide inhibition of KATP channels in vascular smooth muscle, then the present results support the view that adenosine is a normal regulator of cerebrovascular tone and CBF (Ru bio et aI., 1978; Winn et aI., 1981b) . They also suggest a unifying hypothesis that includes both adenosine and KATP channels as components of a mechanism common to both the adjustment of CBF to functional activation and increased energy demand and inadequate substrate supply (Fig. 3) . Energy metabolism is stimulated in neu ral tissue by increased spike activity that activates Na+,K+-ATPase activity to restore ionic gradients across the cell membranes (Mata et aI., 1980; Kadekaro et aI., 1985) . The consequent lowering of the A TP to ADP ratio and increase in inorganic phosphate (Pi) stimulates both glycolysis and electron transport. Electrical stimulation of brain tissue in vitro has also been shown to result in release of adenosine and its metabolites from the tissue (Pull and McIlwain, 1972) . Glucose deprivation caused by hypoglycemia or inhibition of glycolysis with phar macologic doses of 2-DG (Chapman et aI., 1981; Hori naka et aI., 1997a) , hypoxia (Kety and Schmidt, 1948; Rubio et aI., 1975) , and bicuculline-induced seizures (Meldrum and Nilsson, 1976; Winn et aI., 1981c) , are also conditions in which both CBF and brain adenosine levels are elevated. In addition, there are conditions, such as hypotension (Winn et aI., 1980) and ischemia (Winn et aI., 1979) , in which, for obvious reasons, CBF does not increase, but in which brain adenosine levels rise and cerebral vessels dilate. In all these conditions the A TP to ADP ratio tends to fall and ADP levels tend to increase because of either overutilization or underproduction of ATP. Increased ADP leads to increased AMP by the action of the ubiquitous enzyme adenyl ate kinase, thus providing substrate for 5' -nucleotidase to produce aden osine. Adenosine action at smooth muscle A2 receptors produces cyclic AMP, which has, in fact, been shown to increase in brain tissue during electrical stimulation (Ashcroft, 1994; Hamada et aI., 1994; Kleppisch and Nelson, 1995; Roch et aI., 1995; Xu et aI., 1996) . This cascade is initiated by increased ADP levels, which lead to formation and release of adenosine by brain tis sue, followed by adenosine's action on caffeine-sensitive adenosine receptors on smooth muscle cells, and culmi nating in opening of the glibenclamide-sensitive K+ channels. This sequence is presented diagrammatically in Fig. 3 . This hypothesis does not require the assumption of an J Cereb Blood Flow Metab. Vol. 17, No. 12, 1997 obligatory sequential relationship, e,g., "tight cou pling," between rates of glycolysis or oxidative metabo lism and CBF. One is not a direct consequence of the other. Both are derived from the same initial chemical change, a shift in the balance from ATP to ADP, and then evolve by parallel, separate, independent mechanisms (Fig. 3) . Because the shift from ATP to ADP ratio can stimulate both energy metabolism and adenosine forma tion and increased CBF, there may appear to be a so called coupling of the two, but it is more a correlation than a true coupling. Metabolism and CBF can and do sometimes vary independently as, for example, in the moderate degrees of hypoglycemia used in the present studies (Suda et aI., 1990; Horinaka et aI. 1997a ).
There are some caveats to consider before this hypoth esis can be accepted. First, it assumes that the effects of caffeine and glibenclamide observed in this study re sulted from their specific actions at the levels of the adenosine receptors and KATP channels in the vascular smooth muscle. This assumption may be hazardous, par ticularly with respect to caffeine, which may have other actions as well. Caffeine has localized effects on glucose utilization in the brain (Nehlig et a!., 1984) and inhibits cyclic nucleotide phosphodiesterases, which degrade cy clic AMP and cyclic GMP. It may even have a direct effect on the KATP channels, bypassing the adenosine receptors. For example, caffeine has been reported to increase intracellular Ca 2 + concentration in pancreatic j3-cells by directly inhibiting the KATP channels, which leads to depolarization-induced opening of L-type volt age-dependent Ca 2 + channels (Islam et aI., 1995) . In this study we deliberately chose caffeine because of its non specificity toward the various adenosine receptors as we were uncertain which might be involved. Obviously more investigation on the effects of more specific aden osine receptor antagonists on the increases in CBF asso ciated with glucose deprivation or functional activation are needed. We are currently pursuing such studies.
